Categories of Articles

«  Visit AACR Journals' Instructions for Authors

SmartSubmit

The following types of articles will be considered for publication. Note that word counts are exclusive of references. Authors are advised that submissions not adhering to the guidelines provided below, including word counts, may be returned unreviewed. See About Blood Cancer Discovery for important information about the journal, including the scope. The AACR journals Instructions for Authors provides detailed general instructions for authors submitting to any AACR journal.

Where applicable, the Editors-in-Chief and members of the senior editorial board reserve the right to edit the titles, abstracts, and statements of significance for articles that are accepted to improve their clarity, brevity, and quality.

Research Articles

Research articles report on original studies with broad impact across the fields of basic, translational, and clinical research on all subtypes of hematologic malignancies. The reports should be of exceptional significance to a diverse audience of cancer researchers and scientists.

Research Briefs

Research Briefs may report on early clinical data or discovery-based studies that are not sufficiently developed for publication as Research Articles but have the potential to make a significant impact on research areas and/or patient care.

Reviews

Articles that review a timely subject important to cancer researchers. Reviews must be written as concisely as possible. Authors of unsolicited Review Articles must first submit an outline of the proposed article for consideration (E-mail: bloodcancerdiscov@aacr.org). All Review Articles, whether invited or not, will be subject to peer review.

Letters to the Editor

In the spirit of open scientific dialogue, the Editors invite the submission of correspondence that presents considered opinions in response to articles published in the journal. Letters to the Editor will be peer reviewed and, if found to meet the requisite publication criteria (scholarly commentary on a subject of importance and interest to the broad readership), the Letter may be sent to the author(s) of the originally published article and possibly to other interested parties for a response to be published in the same issue of the journal as the Letter. Please note that the journal will not consider Letters to the Editor regarding Blood Cancer Discovery that were published more than 3 months prior. Correspondence concerning articles that have not been published in Blood Cancer Discovery will not be considered.

 


 

Blood Cancer Discovery Editorial Office
American Association for Cancer Research  |  Publications Division
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9354  |  E-mail:  bloodcancerdiscov@aacr.org